MASHINIi

NANOREPRO AG.

NN6.XETRA | Manufacture of pharmaceuticals, medicinal chemical and botanical products

NANOREPRO AG, based in Germany, develops, manufactures, and distributes rapid diagnostic tests for various applications, including human and veterinary medicine, as well as environmental and food safety. Their product portfolio includes tests for detecting infectious diseases, allergies, and other h...Show More

Ethical Profile

Mixed.

NANOREPRO AG develops rapid diagnostic tests, contributing to early detection of infectious diseases and better health outcomes. The company holds CE marking and ISO certifications, with its Nano-Check COVID-19 Antigen Test receiving FDA substantial equivalence. However, reports suggest a lack of specific data on product price accessibility and reach for vulnerable populations. The company also experienced a significant revenue decrease in 2023, which could impact future health investments. For other ethical areas like worker respect, fair trade, environmental impact, or animal welfare, there is currently insufficient public information to provide a comprehensive assessment.

Value Scores

Better Health for All20
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

20

The company's core business is the development, manufacture, and distribution of 24 different rapid diagnostic tests for various applications, including human and veterinary medicine, and environmental and food safety.

1
These products, such as the Nano-Check COVID-19 Antigen Test, are intended to aid in diagnosis, providing exceptional health benefits.
2
There is no evidence of any products with negative health impacts. The Nano-Check COVID-19 Antigen Test demonstrated a Negative Percent Agreement (NPA) of 99.62% and a Positive Percent Agreement (PPA) of 83.67% in clinical performance, with no cross-reactivity with 43 potential pathogens or interference from various substances.
3
The company holds CE marking and certifications including DIN EN ISO 9001, DIN EN ISO 13485, and EC Certificate (98/79/EC), indicating strong regulatory compliance and safety standards.
4
The FDA issued a substantial equivalence determination for its COVID-19 test.
5
The COVID-19 antigen test was intended for use as an aid in diagnosis during the pandemic, demonstrating a contribution to global health crisis response.
6

Fair Money & Economic Opportunity

0

NANOREPRO AG develops, manufactures, and distributes rapid diagnostic tests and food supplements.

1
Multiple articles confirm the company's core business is in the healthcare sector, specifically diagnostics and research. No evidence is provided in any article that NANOREPRO AG offers lending, insurance, or any other financial services or products to consumers or businesses.
2
Therefore, all KPIs related to fair money and economic opportunity are not applicable to the company's operations.

Fair Pay & Worker Respect

0

No specific, concrete data points for any of the 'Fair Pay & Worker Respect' KPIs were found for NANOREPRO AG (NN6.XETRA) in the provided articles.

1
Multiple articles explicitly state that information for these metrics is insufficient or not available for the company.
2
Data pertaining to other companies or general industry trends was not considered relevant to NN6.XETRA.

Fair Trade & Ethical Sourcing

0

No specific quantitative evidence was found in the provided articles to assess NANOREPRO AG against the Fair Trade & Ethical Sourcing KPIs. While a code of ethics outlines a commitment to ethical sourcing and responsible procurement, this document does not provide performance data such as percentages of certified spend, audit frequencies, incident numbers, or traceability coverage.

1
Other articles are either general in nature, discuss fair trade certification processes without company-specific application, or are irrelevant to the company's ethical sourcing performance.

Honest & Fair Business

0

No evidence available to assess NANOREPRO AG on Honest & Fair Business.

Kind to Animals

0

No evidence available to assess NANOREPRO AG on Kind to Animals.

No War, No Weapons

0

The provided articles do not contain any specific, concrete information or data points regarding NN6.XETRA's association with arms manufacturing, military contracts, dual-use technology, sales to embargoed regimes, or any peacebuilding initiatives. Therefore, no assessment can be made against the 'No War, No Weapons' ethical value based on the evidence provided.

Planet-Friendly Business

0

No evidence was found in the provided articles regarding NANOREPRO AG's planet-friendly business practices, environmental impact, or sustainability metrics.

1
All articles explicitly state that they focus on financial data and do not contain information relevant to the requested planet-friendly business metrics.
2

Respect for Cultures & Communities

0

No specific, concrete data points were found across the provided articles to assess NANOREPRO AG against any of the KPIs for the 'Respect for Cultures & Communities' value. The articles primarily focus on financial performance, product certifications, and general company information, without detailing community engagement, cultural impact assessments, or related initiatives for NANOREPRO AG.

Safe & Smart Tech

0

No specific, concrete evidence was found in the provided articles regarding NN6.XETRA's performance across any of the 'Safe & Smart Tech' KPIs. The articles discuss general data breach trends and incidents related to other companies, but do not provide information on NANOREPRO AG's data protection, cybersecurity, or AI ethics practices.

1
, which is a company profile for Nanorepro AG, only provides an SDG Transparency Score, which is not relevant to the KPIs in this rubric.
2

Zero Waste & Sustainable Products

0

No specific, concrete evidence was found in the provided articles for NN6.XETRA (NANOREPRO AG) regarding any of the KPIs related to Zero Waste & Sustainable Products. The articles either discuss the broader nano-enabled packaging market, general sustainability reporting, or provide data for a different company (Oxford Nanopore Technologies), which is not applicable to NN6.XETRA.

Own NANOREPRO AG?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.